Andrew Sinclair does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verona Pharma plc, Adicet Bio, Inc., Sierra Oncology, Inc., and SOLENO THERAPEUTICS INC.

2023 was Andrew Sinclair's most active year for acquiring shares with 9 total transactions. Andrew Sinclair's most active month to acquire stocks was the month of May. 2023 was Andrew Sinclair's most active year for disposing of shares, totalling 5 transactions. Andrew Sinclair's most active month to dispose stocks was the month of July. 2021 saw Andrew Sinclair paying a total of $0.00 for 226,190 shares, this is the most they've acquired in one year. In 2023 Andrew Sinclair cashed out on 100,400 shares for a total of $0.00, their largest year based on trade value.